Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Katarzyna Kotfis and Kacper Lechowicz.
Katarzyna Kotfis
Connection Strength
1.622
Kacper Lechowicz
  1. COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection. J Clin Med. 2020 Jun 19; 9(6).
    View in: PubMed
    Score: 0.888
  2. COVID-19-The Potential Beneficial Therapeutic Effects of Spironolactone during SARS-CoV-2 Infection. Pharmaceuticals (Basel). 2021 Jan 17; 14(1).
    View in: PubMed
    Score: 0.231
  3. COVID-19: The Influence of ACE Genotype and ACE-I and ARBs on the Course of SARS-CoV-2 Infection in Elderly Patients. Clin Interv Aging. 2020; 15:1231-1240.
    View in: PubMed
    Score: 0.223
  4. COVID-19: Pain Management in Patients with SARS-CoV-2 Infection-Molecular Mechanisms, Challenges, and Perspectives. Brain Sci. 2020 Jul 20; 10(7).
    View in: PubMed
    Score: 0.223
  5. FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy. Drug Resist Updat. 2020 12; 53:100719.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.